The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. [electronic resource]
Producer: 20040203Description: 459-68 p. digitalISSN:- 1533-4406
- Administration, Oral
- Aged
- Biomarkers -- blood
- Biopsy
- Bone Density -- drug effects
- Bone and Bones -- metabolism
- Calcium -- therapeutic use
- Clinical Trials, Phase III as Topic
- Double-Blind Method
- Female
- Femur Neck
- Fractures, Spontaneous -- prevention & control
- Humans
- Lumbar Vertebrae -- diagnostic imaging
- Middle Aged
- Organometallic Compounds -- adverse effects
- Osteoporosis, Postmenopausal -- complications
- Prospective Studies
- Radiography
- Risk
- Secondary Prevention
- Spinal Fractures -- etiology
- Strontium -- blood
- Thiophenes -- adverse effects
- Thoracic Vertebrae -- diagnostic imaging
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.